Issues related to oncology, Medicare coverage, domestic production of essential drugs, supply chain security, PILLS Act, Biosecure Act, Loans and grants for biologic production
2025 · 4th Quarter (Oct 1 - Dec 31)
COHERUS BIOSCIENCES, INC.
Filed by COHERUS BIOSCIENCES.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Oct 22, 2025
- Income
- Not reported
- Expenses
- $80,000.00
- Registrant
- COHERUS BIOSCIENCES
- Filing UUID
- 15f3b228-0de5-44ab-a596-59c520fbebaf
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Issues related to drug development, oncology, IRA implementation, supply chain security, BIOSECURE as a policy matter, PILLS Act, and domestic production of essential drugs. Strategic National Stockpile of acute radiation syndrome medical counter measures. Administration for Strategic Preparedness & Response.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.